Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression-Reference-Cited by-同舟云学术

Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

Published:2016-11-09 Issue:1 Volume:14 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Scarpignato Carmelo, ,Gatta Luigi,Zullo Angelo,Blandizzi Corrado,

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-016-0718-z.pdf

Reference491 articles.

1. Scarpignato C, Pelosini I, Di Mario F. Acid suppression therapy: where do we go from here? Dig Dis. 2006;24:11–46.

2. Hunt RH. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005. Aliment Pharmacol Ther. 2005;22 Suppl 3:10–9.

3. Scarpignato C, Pelosini I. Review article: the opportunities and benefits of extended acid suppression. Aliment Pharmacol Ther. 2006;23 Suppl 2:23–34.

4. Scarpignato C, Hunt RH. Proton pump inhibitors: the beginning of the end or the end of the beginning? Curr Opin Pharmacol. 2008;8:677–84.

5. Hunt RH, Scarpignato C. Potassium-competitive acid blockers (P-CABs): are they finally ready for prime time in acid-related disease? Clin Transl Gastroenterol. 2015;6, e119.

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Proton Pump Inhibitors in Patients with Liver Cirrhosis: Real Life Experience;Journal of Clinical Medicine;2024-08-30

2. The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System;PharmacoEconomics - Open;2024-08-27

3. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

4. Effectiveness of high‐dose esomeprazole or pantoprazole 10‐day sequential therapy empirically prescribed in Helicobacter pylori‐infected naïve patients: a retrospective study;Journal of Gastroenterology and Hepatology;2024-08-26

5. Gastroesophageal Reflux Disease: New Insights and Treatment Approaches;Cureus;2024-08-24